Telomerase inhibitors as novel antitumor drugs

被引：0
|
作者：
A. I. Glukhov
L. V. Svinareva
S. E. Severin
V. I. Shvets
机构：
[1] Sechenov Medical Academy,
[2] Moscow Research Institute of Medical Ecology,undefined
[3] Lomonosov Moscow State Academy of Fine Chemical Technology,undefined
来源：
Applied Biochemistry and Microbiology | 2011年 / 47卷
关键词：
antisense therapy; immortalization; G-quadruplex; ribozyme; RNA interference; telomerase activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Telomerase activity is detected in most types of human tumors, but it is almost undetectable in normal somatic cells; therefore, telomerase is a promising therapeutic target. The present review describes various approaches to telomerase inhibition, namely, antisense therapy, RNA interference, and the use of ribozymes and agents interacting with the telomeric G-quadruplex. The use of these compounds in clinical research is analyzed in the review.
引用
收藏
页码：655 / 660
页数：5
相关论文
共 50 条
  • [21] The development of novel telomerase inhibitors: Structure-activity relationships
    Cheng, MK
    Modi, C
    Grindon, CR
    Stevens, MFG
    Laughton, CA
    BRITISH JOURNAL OF CANCER, 2003, 88 : S40 - S40
  • [22] Rutaceous alkaloids as models for the design of novel antitumor drugs
    François Tillequin
    Phytochemistry Reviews, 2007, 6 (1) : 65 - 79
  • [23] Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules
    Ngan, VK
    Bellman, K
    Panda, D
    Hill, BT
    Jordan, MA
    Wilson, L
    CANCER RESEARCH, 2000, 60 (18) : 5045 - 5051
  • [24] NOVEL NUCLEOSIDE INHIBITORS OF GUANOSINE METABOLISM AS ANTITUMOR AGENTS
    SMEJKAI, RM
    PAGE, TT
    BOYD, VL
    NYHAN, WL
    JACOBSEN, SJ
    MANGUM, JH
    ROBINS, RK
    ADVANCES IN ENZYME REGULATION, 1984, 22 : 59 - 68
  • [25] Discovery and antitumor evaluation of novel inhibitors of spermine oxidase
    Sun, Lidan
    Yang, Jianlin
    Qin, Yu
    Wang, Yanlin
    Wu, Hongyan
    Zhou, You
    Cao, Chunyu
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 1140 - 1151
  • [26] Novel Aminopeptidase N Inhibitors with Improved Antitumor Activities
    Wang, Qiang
    Shi, Qiao
    Huang, Lu
    LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (01) : 98 - 106
  • [27] Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents
    Thurnher, Martin
    Nussbaumer, Oliver
    Gruenbacher, Georg
    CLINICAL CANCER RESEARCH, 2012, 18 (13) : 3524 - 3531
  • [28] Are we close to the clinical development of novel drugs targeting telomeres and telomerase?
    D'Incalci, M
    Zupi, G
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (07) : 970 - 970
  • [29] Development of telomerase inhibitors
    Rowley, PT
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (12) : 1815 - 1823
  • [30] Human telomerase inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (11) : 523 - 523
12345